TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism. Issue 11 (November 2018)

• Record Type: Journal Article
• Authors: de Lima, Kalil; Donate, Paula; Talbot, Jhimmy; Davoli-Ferreira, Marcela; Peres, Raphael; Cunha, Thiago; Alves-Filho, José; Cunha, Fernando
• Is Part Of: Cell death and disease. Volume 9:Issue 11(2018)
• Page Start: 1
• Page End: 10
• Publication Date: 2018-11
• Subjects: Cell death -- Periodicals; Apoptosis -- Periodicals; 571.936
• DOI: 10.1038/s41419-018-1107-7
• Languages: English
• ISSNs: 2041-4889

Abstract

Abstract The aryl hydrocarbon receptor (AHR) is a transcription factor activated by ligand highly expressed on TH 17 cells, and AHR-deficient CD4+ T cells have impaired production of IL-17A and IL-22. Although AHR activation can exacerbate in vivo TH 17 cell-mediated autoimmunity, accumulating data indicate that AHR is a nonpathogenic TH 17 marker. Thus it remains unclear how AHR activation is regulated and impacts on the generation of TH 17 subsets. Here we demonstrated that AHR pathway is activated during in vitro pathogenic TH 17 polarization, but it is quickly downregulated. Under these conditions, additional AHR activation promoted IL-22 but not IL-17A. Interestingly, AHR high sustained expression and IL-17A promotion were only achieved when TGFβ1 was present in the culture. In addition to the effect on AHR regulation, TGFβ1 presented a dual role by simultaneously suppressing the TH 17 pathogenic phenotype acquisition. This latter effect was independent of AHR stimulation, since its activation did not confer a TH 17 anti-inflammatory profile andAhr − /− cells did not upregulate any TH 17 pathogenic marker. Through the use of EAE model, we demonstrated that AHR is still functional in encephalitogenic CD4+ T cells and the adoptive transfer ofAhr − /− TH 17 cells to recipient mice resulted in milder EAE development when compared to their WT counterparts. Altogether, our data demonstrated that although AHR is highly expressed on in vitro-generated nonpathogenic TH 17 cells, its ligation does not shift TH 17 cells to an anti-inflammatory phenotype. Further studies investigating the role of AHR beyond TH 17 differentiation may provide a useful understanding of the physiopathology of autoimmune diseases.